Suzanne Zoumaras - Surgalign Holdings Chief Officer

SRGADelisted Stock  USD 0.04  0  12.54%   

Insider

Suzanne Zoumaras is Chief Officer of Surgalign Holdings
Age 59
Phone224 303 4651
Webhttps://www.surgalign.com

Surgalign Holdings Management Efficiency

The company has return on total asset (ROA) of (0.3494) % which means that it has lost $0.3494 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (14.9702) %, meaning that it created substantial loss on money invested by shareholders. Surgalign Holdings' management efficiency ratios could be used to measure how well Surgalign Holdings manages its routine affairs as well as how well it operates its assets and liabilities.
Surgalign Holdings currently holds 10.19 M in liabilities with Debt to Equity (D/E) ratio of 0.54, which is about average as compared to similar companies. Surgalign Holdings has a current ratio of 2.28, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Surgalign Holdings' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Joseph PowersSi Bone
64
Mojirade JamesAvanos Medical
57
Danielle WatsonHeart Test Laboratories
42
Jared OasheimCVRx Inc
41
Jeff WelchBioventus
N/A
B JohnsonParagon 28
68
Agnes LeeInogen Inc
N/A
John MeduriAccelerate Diagnostics
N/A
Michelle ScharfenbergAvanos Medical
N/A
Jennifer ErnstTivic Health Systems
56
Kerr HolbrookAvanos Medical
57
Christopher YamamotoBioventus
N/A
Mark HughesHyperfine
61
Ed JoyceAxogen Inc
N/A
Matt JarboeParagon 28
N/A
Ehab EsmailOrthofix Medical
52
Anthony JamesBioventus
N/A
David CrawfordAvanos Medical
N/A
Jason EdieParagon 28
N/A
Salvador DadaEstablishment Labs Holdings
42
Alessandraa PavesioBioventus
57
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois. Surgalign Hldg operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 231 people. Surgalign Holdings (SRGA) is traded on NASDAQ Exchange in USA and employs 217 people.

Management Performance

Surgalign Holdings Leadership Team

Elected by the shareholders, the Surgalign Holdings' board of directors comprises two types of representatives: Surgalign Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Surgalign. The board's role is to monitor Surgalign Holdings' management team and ensure that shareholders' interests are well served. Surgalign Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Surgalign Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
Christopher Thunander, VP Officer
William Durall, Chief Officer
Enrico Sangiorgio, Ex International
David Lyle, Chief Officer
Suzanne Zoumaras, Chief Officer
Olivier Visa, Pres OEM
Paolo Amoruso, Gen Officer
Terry Rich, CEO Pres
Bob Watkins, Chief Officer
John Varela, Ex Operations

Surgalign Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Surgalign Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Consideration for investing in Surgalign Stock

If you are still planning to invest in Surgalign Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Surgalign Holdings' history and understand the potential risks before investing.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Commodity Directory
Find actively traded commodities issued by global exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Bonds Directory
Find actively traded corporate debentures issued by US companies
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume